KRAS and pancreatic ductal adenocarcinoma: Mutations in Kras or TP53, which are frequently detected in ductal adenocarcinoma of the pancreas, were significantly less frequently observed in pancreatic neuroendocrine neoplasia (PanNEN) [19].